Procter & Gamble Hygiene & Health Care Ltd. (PGHH) AI Stock Analysis

• Market Cap: ₹414.75B
• Dividend Yield: 2.07%
• Average Volume (3M): 854.00
• Price to Earnings (P/E): 50.2
• Beta (1Y): 0.36
• Revenue Growth: 8.28%
• EPS Growth: 11.65%
• Country: IN
• Employees: 439
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 64.65
• Shares Outstanding: 32,460,735
• 10 Day Avg. Volume: 1,521
• 30 Day Avg. Volume: 854
• PEG Ratio: 2.02
• Price to Book (P/B): 59.85
• Price to Sales (P/S): 9.80
• P/FCF Ratio: 78.41
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 63 Neutral
• Price Target: ₹14,470.00 ▲(11.17% Upside)

Procter & Gamble Hygiene & Health Care Ltd. demonstrates strong financial performance with consistent growth and profitability, which is the most significant factor in its overall score. The technical analysis indicates a bearish trend, and the valuation suggests the stock may be overvalued, slightly offsetting the strong financials. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Strong Financial Health

A low debt-to-equity ratio indicates a strong balance sheet, reducing financial risk and enhancing stability, which supports long-term growth.

Efficient Cash Flow Management

Strong operating cash flow ensures the company can sustain operations, invest in growth, and return value to shareholders, enhancing financial flexibility.

Robust Profitability

High profitability margins indicate efficient operations and cost management, providing a competitive edge and supporting sustainable growth.

Negative Factors

Volatility in Free Cash Flow Growth

Volatility in free cash flow growth can impact the company's ability to plan long-term investments and may affect financial predictability.

High Valuation Concerns

A high P/E ratio can indicate overvaluation, potentially limiting upside potential and making the stock less attractive for value-focused investors.

Limited Recent Corporate Developments

Lack of recent corporate developments may suggest stagnation in strategic initiatives, potentially impacting future growth and innovation.

Procter & Gamble Hygiene & Health Care Ltd. Business Overview & Revenue Model

Company Description

Procter & Gamble Hygiene & Health Care Ltd. (PGHH) is a subsidiary of the global consumer goods giant Procter & Gamble, specializing in hygiene and health care products. The company operates primarily in the fast-moving consumer goods (FMCG) sector, offering a range of products including personal care items, health supplements, and hygiene essentials. PGHH is known for its commitment to innovation and quality, serving a diverse customer base and enhancing everyday life with trusted brands.

How the Company Makes Money

PGHH generates revenue through the sale of its wide array of hygiene and health care products, which are distributed through various channels including retail stores, e-commerce platforms, and direct sales. The company employs a business model centered around brand loyalty and market penetration, benefiting from established brand recognition and customer trust in its products. Key revenue streams include sales of personal care products like shampoos and skin care items, as well as health care products such as over-the-counter medicines and dietary supplements. Additionally, PGHH may engage in strategic partnerships with retailers and distributors to enhance product availability and visibility, contributing to its overall sales performance.

Procter & Gamble Hygiene & Health Care Ltd. Financial Statement Overview

Summary

Procter & Gamble Hygiene & Health Care Ltd. exhibits a strong financial position across all verticals. The income statement reflects consistent growth and profitability, the balance sheet indicates financial stability with low leverage, and the cash flow statement shows strong cash generation capabilities. The company is well-positioned to sustain its growth trajectory and manage potential risks effectively.

Income Statement

Procter & Gamble Hygiene & Health Care Ltd. demonstrates strong financial performance with consistent revenue growth and healthy profit margins. The gross profit margin remains robust, indicating efficient cost management, while the net profit margin shows solid profitability. The EBIT and EBITDA margins are stable, reflecting effective operational management. Overall, the income statement reflects a positive growth trajectory and profitability.

Balance Sheet

The company's balance sheet is characterized by a very low debt-to-equity ratio, indicating minimal leverage and financial stability. The return on equity is strong, showcasing effective utilization of shareholder funds to generate profits. The equity ratio is healthy, suggesting a solid capital structure. However, a slight decrease in stockholders' equity over the years could be a point of concern.

Cash Flow

The cash flow statement reveals a positive trend in free cash flow growth, indicating strong cash generation capabilities. The operating cash flow to net income ratio is healthy, suggesting efficient conversion of income into cash. The free cash flow to net income ratio is also strong, reflecting the company's ability to generate cash relative to its net income. Overall, the cash flow position is robust, supporting the company's operational and strategic initiatives.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	43.02B	44.99B	42.06B	39.05B	39.01B	35.70B
Gross Profit	25.84B	25.48B	25.76B	22.42B	17.17B	22.42B
EBITDA	12.11B	12.11B	10.22B	8.98B	8.43B	9.18B
Net Income	7.18B	8.49B	6.75B	6.78B	5.76B	6.52B
Balance Sheet
Total Assets	17.55B	17.55B	18.59B	21.37B	16.81B	16.33B
Cash, Cash Equivalents and Short-Term Investments	5.16B	5.16B	5.74B	9.64B	6.25B	6.48B
Total Debt	23.20M	23.20M	30.80M	40.30M	51.00M	34.70M
Total Liabilities	10.18B	10.18B	10.84B	11.91B	9.44B	9.18B
Stockholders Equity	7.37B	7.37B	7.75B	9.46B	7.38B	7.14B
Cash Flow
Free Cash Flow	5.15B	5.63B	4.26B	7.81B	5.23B	8.32B
Operating Cash Flow	5.73B	6.18B	4.71B	8.26B	5.73B	8.63B
Investing Cash Flow	-525.30M	-586.30M	10.60M	-99.10M	-268.50M	69.40M
Financing Cash Flow	-12.19B	-6.66B	-8.62B	-4.77B	-5.69B	-11.06B

Procter & Gamble Hygiene & Health Care Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 13015.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PGHH, the sentiment is Neutral. The current price of 13015.9 is above the 20-day moving average (MA) of 12762.97, below the 50-day MA of 13152.54, and below the 200-day MA of 13454.58, indicating a neutral trend. The MACD of -41.79 indicates Negative momentum. The RSI at 54.97 is Neutral, neither overbought nor oversold. The STOCH value of 78.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:PGHH.

Procter & Gamble Hygiene & Health Care Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COLPAL	70 Outperform	₹574.04B	43.29	―	2.42%	-2.06%	-9.74%
DABUR	66 Neutral	₹876.65B	48.44	―	1.62%	2.68%	1.07%
ZYDUSWELL	66 Neutral	₹135.78B	53.58	―	0.28%	14.55%	-20.61%
EMAMILTD	64 Neutral	₹227.95B	30.06	―	1.91%	0.84%	-2.44%
PGHH	63 Neutral	₹414.75B	50.18	―	2.07%	8.28%	11.65%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
GILLETTE	56 Neutral	₹260.24B	45.34	―	1.40%	7.42%	22.99%

Procter & Gamble Hygiene & Health Care Ltd. Corporate Events

Procter & Gamble Hygiene and Health Care Ensures Regulatory Compliance with SEBI Regulations

Procter & Gamble Hygiene and Health Care Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. This certificate confirms that all securities received for dematerialization during this period have been processed appropriately, with confirmations sent to depositories and necessary updates made to the register of members. The announcement underscores the company’s compliance with regulatory requirements, ensuring transparency and trust with its stakeholders.